News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
254,301 Results
Type
Article (14065)
Company Profile (23)
Press Release (240208)
Multimedia
Podcasts (25)
Webinars (3)
Section
Business (71709)
Career Advice (1125)
Deals (14542)
Drug Delivery (55)
Drug Development (34731)
Employer Resources (47)
FDA (6689)
Job Trends (5836)
News (126001)
Policy (10371)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
Academia (788)
Accelerated approval (22)
Adcomms (7)
Allergies (91)
Alliances (11304)
ALS (113)
Alzheimer's disease (732)
Antibody-drug conjugate (ADC) (269)
Approvals (7093)
Artificial intelligence (328)
Autoimmune disease (142)
Automation (25)
Bankruptcy (111)
Best Places to Work (4938)
BIOSECURE Act (4)
Biosimilars (139)
Biotechnology (22)
Bladder cancer (151)
Brain cancer (41)
Breast cancer (477)
Cancer (3529)
Cardiovascular disease (289)
Career advice (903)
Career pathing (13)
CAR-T (154)
CDC (13)
Cell therapy (424)
Cervical cancer (29)
Clinical research (32721)
Collaboration (1083)
Compensation (590)
Complete response letters (24)
COVID-19 (1062)
CRISPR (50)
C-suite (417)
Cystic fibrosis (68)
Data (4919)
Decentralized trials (1)
Depression (101)
Dermatology (50)
Diabetes (311)
Diagnostics (2585)
Digital health (21)
Diversity (1)
Diversity, equity & inclusion (13)
Drug discovery (163)
Drug pricing (76)
Drug shortages (13)
Duchenne muscular dystrophy (166)
Earnings (54367)
Editorial (23)
Employer branding (10)
Employer resources (44)
Events (36994)
Executive appointments (488)
FDA (8842)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (9)
Frontotemporal dementia (23)
Funding (959)
Gene editing (117)
Generative AI (23)
Gene therapy (356)
GLP-1 (650)
Government (1618)
Grass and pollen (5)
Guidances (368)
Healthcare (6909)
HIV (51)
Huntington's disease (26)
IgA nephropathy (62)
Immunology and inflammation (152)
Immuno-oncology (49)
Indications (104)
Infectious disease (1268)
Inflammatory bowel disease (94)
Inflation Reduction Act (6)
Influenza (97)
Intellectual property (108)
Interviews (198)
IPO (8541)
IRA (11)
Job creations (1191)
Job search strategy (775)
JPM (34)
Kidney cancer (16)
Labor market (47)
Layoffs (209)
Leadership (15)
Legal (2119)
Liver cancer (57)
Longevity (9)
Lung cancer (516)
Lymphoma (304)
Machine learning (29)
Management (11)
Manufacturing (436)
MASH (106)
Medical device (5127)
Medtech (5169)
Mergers & acquisitions (6733)
Metabolic disorders (866)
mRNA (78)
Multiple sclerosis (106)
NASH (11)
Neurodegenerative disease (226)
Neuropsychiatric disorders (71)
Neuroscience (1562)
NextGen: Class of 2026 (2073)
Non-profit (1551)
Now hiring (36)
Obesity (435)
Opinion (86)
Ovarian cancer (114)
Pain (128)
Pancreatic cancer (144)
Parkinson's disease (207)
Partnered (12)
Patents (218)
Patient recruitment (286)
Peanut (34)
People (9303)
Pharmaceutical (11)
Pharmacy benefit managers (11)
Phase 1 (8842)
Phase 2 (14114)
Phase 3 (12498)
Pipeline (5292)
Policy (73)
Postmarket research (1213)
Preclinical (3055)
Press Release (15)
Prostate cancer (193)
Psychedelics (25)
Radiopharmaceuticals (135)
Rare diseases (572)
Real estate (1353)
Recruiting (20)
Regulatory (9260)
Reports (26)
Research institute (828)
Resumes & cover letters (209)
Rett syndrome (30)
RNA editing (9)
RSV (61)
Schizophrenia (107)
Series A (145)
Series B (115)
Service/supplier (3)
Sickle cell disease (57)
Special edition (12)
Spinal muscular atrophy (94)
Sponsored (15)
Startups (1160)
State (1)
Stomach cancer (7)
Supply chain (62)
Tariffs (31)
The Weekly (24)
Vaccines (534)
Venture capital (51)
Weight loss (306)
Women's health (56)
Worklife (10)
Date
Today (80)
Last 7 days (426)
Last 30 days (1454)
Last 365 days (18010)
2026 (5377)
2025 (18208)
2024 (16898)
2023 (16187)
2022 (20646)
2021 (20271)
2020 (19028)
2019 (16794)
2018 (12749)
2017 (11970)
2016 (10566)
2015 (12717)
2014 (9228)
2013 (7262)
2012 (7941)
2011 (8061)
2010 (7267)
Location
Africa (322)
Alabama (31)
Alaska (2)
Arizona (104)
Arkansas (6)
Asia (16373)
Australia (2502)
California (7340)
Canada (1985)
China (744)
Colorado (297)
Connecticut (373)
Delaware (267)
Europe (36683)
Florida (898)
Georgia (193)
Hawaii (3)
Idaho (19)
Illinois (583)
India (42)
Indiana (318)
Iowa (12)
Japan (380)
Kansas (57)
Kentucky (19)
Louisiana (23)
Maine (50)
Maryland (754)
Massachusetts (5174)
Michigan (133)
Minnesota (323)
Mississippi (5)
Missouri (82)
Montana (9)
Nebraska (8)
Nevada (78)
New Hampshire (34)
New Jersey (2113)
New Mexico (9)
New York (1817)
North Carolina (784)
North Dakota (3)
Northern California (3675)
Ohio (169)
Oklahoma (7)
Oregon (13)
Pennsylvania (1248)
Puerto Rico (13)
Rhode Island (19)
South America (475)
South Carolina (23)
Southern California (2851)
Tennessee (97)
Texas (1165)
United States (24902)
Utah (155)
Virginia (174)
Washington D.C. (33)
Washington State (634)
West Virginia (3)
Wisconsin (108)
Wyoming (2)
254,301 Results for "5".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Nexus Pharmaceuticals Launches Cyclophosphamide Injection, 2.5 mL and 5 mL
April 7, 2026
·
1 min read
Press Releases
NEXGEL New Strategic Partner, Sequence LifeScience™, Leads Financing with $5.5 Million to Complete Acquisition of Celularity Degenerative Disease Segment
April 21, 2026
·
5 min read
Press Releases
Schrödinger to Announce First Quarter 2026 Financial Results on May 5
April 21, 2026
·
1 min read
Press Releases
Tempus to Report First Quarter 2026 Financial Results on May 5
April 21, 2026
·
1 min read
Mergers & acquisitions
5 biopharma M&A deals where the workforce was the prize
Gilead, AstraZeneca and Vertex have acquired more than just a therapeutic asset in recent deals.
BioSpace
takes a look at five recent transactions where the staff was the real centerpiece.
April 15, 2026
·
7 min read
·
Annalee Armstrong
Press Releases
Revvity to Hold Earnings Call on Tuesday, May 5, 2026
April 10, 2026
·
1 min read
Press Releases
IQVIA to Announce First-Quarter 2026 Results on May 5, 2026
April 16, 2026
·
2 min read
Press Releases
INOVIO Announces Pricing of $17.5 Million Public Offering
April 2, 2026
·
4 min read
Press Releases
Marvel Biosciences Secures Financial and Strategic Investment with 5 Horizon Ventures
April 7, 2026
·
6 min read
Press Releases
LeMaitre Will Announce First Quarter 2026 Earnings Results on May 5, 2026
April 15, 2026
·
1 min read
1 of 25,431
Next
